• 월간포장계
• /
• 통권235호
• /
• pp.105-109
• /
• 2012

식품의약품안전청은 안전상비의약품의 약국 외 판매를 도입하는 내용의 "약사법"이 개정(법률 제11421호, 2012. 5. 14.공포)됨에 따라 일반소비자가 안전상비의약품의 효능 효과, 용법 용량 등의 정보를 쉽고 정확하게 이해하여 안전하게 사용할 수 있도록 안전상비의약품의 기재요령을 정하고 기존 고시의 문제점을 보완하고자 의약품 표시 등에 관한 규정 일부개정고시(안)를 행정예고했다. 또한 식약청은 "의약품 표시 등에 관한 규정"이 이미 행정예고(식품의약품안전청 공고 제2012-120호, 2012. 6. 13) 되었으나 안전상비의약품의 용기나 포장에 허가 또는 신고사항 일부를 요약 기재할 수 있도록 "약사법 시행규칙"이 개정 추진됨에 따라 본 고시를 다시 행정예고한다고 밝혔다. 주요 내용에 대해 살펴본다.

• 한국임상약학회지
• /
• 제31권3호
• /
• pp.180-187
• /
• 2021

Objective: We investigated arthralgia and myalgia associated with the use of oral bisphosphonate (BP) by conducting a survey of patient. Methods: The pharmacists conducted a survey between 1 Oct 2019 and 30 Sep 2020 among patients who were dispensed BP in community pharmacies to assess their demographic and medical characteristics, and their experiences with, and process for pain. Logistic regression analyses were performed to find the risk factors associated with the pain, and the odds ratios (OR) and 95% confidence intervals (CI) were determined. Results: A total of 160 patients who used BP participated in the survey (74 [46.3%] used risedronate; 61 [38.1%] used alendronate; 23 [14.4%] used ibandronate), and 20 (12.5%) of them experienced pain. Significant statistical differences of the characteristics between patients who experienced pain or not were observed regarding menopause, and parity. Compared with women who had one or two parity, women who had more than three parity were associated with the decreased risk of pain (OR, 0.24; 95% CI, 0.04-0.98). Moreover, steady exercise was associated with the decreased risk of pain compared to less exercise (OR, 0.37; 95% CI, 0.14-0.98). Conclusion: Our findings suggest that the risk of pain in BP-treated patients might be different regarding the different ingredients of BP, and dosing frequency. This survey highlights a need for a further safety research to understand the factors influencing the pain associated with the BP treatment.

• 대한한약신문
• /
• 통권116호
• /
• pp.1-12
• /
• 2006

2006년도 제3차 회장단 협의회/정부, 약사법.의료법 전면개정안 국회 제출/"한약재 품질관리 강화된다"/생산단계서 의약품으로 구별 관리해야/치료효과 보장.암시하는 의료광고 형사처벌/의료단체 행정소송 이어 연말정산 '헌법소원' 제기/난치성질환 치료에 '한의학' 적극 활용/한의학연, 사상의학 본격 연구/의료비 자료제출 거부기관 세무조사 경고/"한약, 간기능 악화 요인 없다"/의료기관 공진단 취급 '주의 요망'/한의원, 자체 제조한 안약.연고 등 판매불가/"의료비 소득제출 유언비어 살포시 고발조치"/"연말정산 미제출 병의원 세무조사 없다"/복지부, 요양기관 녹색인증제 폐지/소득.학력 높을수록 약국 서비스에 불만족/PD수첩 방영된 한의사 3명 징계 결정/부정합 판정 한약재 취급 업소 행정처분/개원한의사 전문의 면허시험 자격인정 연구/지부탐방-지부장에게 듣는다/칼럼-고쟁이와 자궁병/애증 이야기/명칭이 비슷하여 감별하기 어려운 한약재/성약과 패륜아/우리 약초를 찾아서-치자나무/한방과 항문질환/노인들 아스피린을 상용하면/전호, 오용에 대한 소고

• 문화기술의 융합
• /
• 제8권4호
• /
• pp.303-311
• /
• 2022

최근 COVID-19 이후 한시적 허용을 통해 증가하고 있는 비대면진료 플랫폼 기업에서 온라인 처방약 배송까지 함께 제공하는 경우가 증가하고 있어 이에 대한 기존 의약품공급자들의 우려가 커지는 가운데 적극적인 대응 움직임도 나타나고 있다. 본 연구에서는 게임이론의 시장 진입 저지 모형을 중심으로 기존 의약품공급자의 선제적 적극 대응이 성공적으로 시행될 수 있을 경우 온라인 의약품배송기업의 시장 진입을 억제할 수 있으나, COVID-19 이후 비대면진료의 한시적 허용에 따라 비대면진료 및 처방약 배송 플랫폼의 시장 진입이 효과적으로 이루어진 상황에서는 기존 의약품공급자의 수용적 대응이 보다 합리적인 선택이 될 수 있음을 보였다. 다만, 소비자 편이성 증대 방향의 소매 의약품유통시장 관련 제도 개선에 기존 의약품공급자들이 보다 전향적으로 협력할 수 있도록 온라인 처방약 배송 플랫폼 기업에 참여하는 약사들에 대해 일일 처방전 접수 건수에 상한선을 설정하는 방법, 의약품배송 약국 선택 시 기존 이용 약국 및 의료이용자의 거주지역 지역사회 약국이 우선 소개될 수 있도록 플랫폼 사용자 환경에 노출 방식 및 노출 시간 등을 조정하는 방안, 장기적으로 비대면진료 및 의약품배송 플랫폼 기업의 기업 공개 시 지역사회 약국 등이 자본 참여할 수 있는 방안 등이 고려될 필요가 있다.

• 한국치위생학회지
• /
• 제21권4호
• /
• pp.403-412
• /
• 2021

Objectives: The objectives of this study were to assess oral health knowledge and behavior levels of community pharmacists as a step toward projecting them to play the role of oral health partners and to confirm pharmacists' willingness to participate in oral health education programs. Methods: t-test and one-way analysis of variance were performed to analyze the data, and correlation analysis was also performed. Results: The mean score for pharmacists' oral health knowledge was 7.29 out of 10. Of the 12 questions asked, the correct answer rate was highest for the question about the effect of smoking cessation on periodontal disease prevention; conversely, the correct answer rate was lowest for the question about the effect of taking medication for gingival infections on periodontal disease prevention. The mean score for pharmacists' oral health behavior was 2.97 out of 4 points. Of all oral health behaviors, brushing twice a day was the most practiced, whereas immediately visiting a dentist in case of an oral health issue was the least practiced. Pharmacists' oral health knowledge and behavior levels showed a weak positive correlation with their intention to participate in oral health education programs. Conclusions: Oral health education programs are necessary to improve community pharmacists' oral health knowledge and behavior.

• 한국임상약학회지
• /
• 제19권2호
• /
• pp.159-166
• /
• 2009

The purpose of this study was to evaluate the attitude and knowledge of community pharmacists to spontaneous adverse drug reaction (ADR) reporting. A survey was conducted in 103 community pharmacists in Seoul and Kyung-Gi Province from September to October, 2009. Almost half (53, 51.5%) and three-fourths (79, 76.7%) of respondents knew they could participate in ADR reporting in the Regional Pharmacovigilance Center (RPC) or Korean Food and Drug Administration (KFDA). However, only three of them have reported an ADR to the RPC and none of them have reported to KFDA. A majority of the respondents (96, 93.2%) felt that ADR reporting was a professional obligation for pharmacists. The purpose of an ADR reporting was incorrectly identified by most pharmacists. ADR reporting was encouraged if the reaction was serious and a new product. The most frequently mentioned barriers to reporting were: uncertainty concerning the causal relationship (86.3%) and not knowing how to report an ADR (83.2%). Only 19 (18.4%) respondents had received education on how to report ADR. Education was the most recognized method of improving ADR reporting. This study showed the knowledge of ADR reporting among community pharmacists is inadequate. Education and training should be reinforced in order to improve ADR reporting by community pharmacists.

• 정보처리학회논문지C
• /
• 제10C권3호
• /
• pp.281-286
• /
• 2003

최근 환자의 개인적인 의료정보가 외부에 노출되는 것은 사생활적인 측면뿐 아니라 사회 활동 및 환경에도 영향을 준다. 그러므로 불법적인 조작으로부터 환자의 개인적인 의료정보를 안전히 보호하는 것은 중요하다. 이에 본 논문에서는 첫 번째, IC 카드에 전자처방전 정보를 저장하는 방법을 연구하고 두 번째, IC 카드에 저장된 정보에 접근하기 위한 사용자(의사, 간호사, 의료기관 관계자, 약국, 약사, 환자 등)의 접근 권한을 설계한다. 마지막으로 윈도우즈 2000이 지원하는 인증 관리 모델의 보안 API를 이용하여 인증서를 발급하고, 보안 서비스 제공 프로그램을 이용하여 공개키/개인키를 생성하여, 전자처방전에 대해 전자서명을 한다. 본 논문에서 제시한 시스템은 전자처방전의 안전성과 신뢰성을 확실히 보장할 수 있으며, 진료에 대한 서비스를 향상시킬 수 있을 것으로 기대된다.

• 한국임상약학회지
• /
• 제25권2호
• /
• pp.94-101
• /
• 2015

Background: In order to achieve the goals of community pharmacy practice, its legal, labour-related, and economic barriers need to be identified. This study examined pharmacists' perceptions of constraints on providing optimal pharmacy services in order to identify underlying factors and analyse the associations between barriers and pharmaceutical services in community pharmacies. Methods: A survey targeting pharmacy owners was conducted from May to June 2012 using a structured questionnaire including nine pharmaceutical service items. According to the service provision level, we classified pharmacists as inactive (fewer than 5 items among the listed 9 service items) and active providers (5 or more items). Principal component analysis was used to group significant factors for barriers into four thematic components. Associations between the participants' demographics and pharmacy characteristics and the services provided were explored by logistic regression analyses. Results: Participants were 402 pharmacists. Over 60% provided disease management services for hypertension, diabetes, and hyperlipidaemia. Variables that affected pharmaceutical services included the lack of separate areas for patient counselling (OR: 2.12, 95% CI: 1.18-3.80), and clinical knowledge and information-related barriers (OR: 0.59, 95% CI: 0.36-0.97). Conclusion: Strategies for improving clinical knowledge and providing expeditious information are necessary in order to improve community pharmacy services.

• 한국임상약학회지
• /
• 제27권4호
• /
• pp.228-237
• /
• 2017

Objective: We conducted a survey to understand the current state of pharmacy services and pharmacists' thoughts in the future of the community pharmacy setting. Methods: A questionnaire was distributed to 229 pharmacists and gathered from 95 respondents. Results: We asked to pharmacists about what the ideal pharmacy duty should be in the next 10 years at the community pharmacy setting in Korea. For this question, the respondents said drug counselling (19.4%), dispensing (13.8%), long-term care of chronic disease and healthcare education (12.8%), and OTC counselling (11.5%). When asked about how much time they were spending doing certain tasks in the pharmacy, the main tasks were dispensing (23.5%), counselling (17.1%), prescription review (10.1%), and OTC counselling (5.5%). When asked about what the most important duty of a pharmacist was, medication counselling (45.4%) was the most important task that they identified and the reasons for not being able to fulfill this role properly was time shortage (78.9%) followed by the lack of counselling spaces, up-to-date knowledges, and focus on financial gains over patient counselling. Conclusion: Korean pharmacists are mainly focusing on dispensing in their daily work. Their basic responsibilities can be easily mechanized over the next few years, but the social expectations of disease-prevention and public health promotion both in current and future can not be replaced by such mechanical measures. Therefore, pharmaceutical services in Korea should be developed in more diverse and professional ways.

• 한국임상약학회지
• /
• 제16권1호
• /
• pp.9-13
• /
• 2006

Patient counseling is emerging as one of the most important roles of community pharmacists because the information on the standard labeling for the prescription drug is not sufficient to ensure the correct use of the drug. However, excessive workload of the community pharmacists in Korea discourages the provision of the effective patient counseling. The use of auxiliary label may be an efficient tool to help patients correctly use the prescription drug in this situation. As a preliminary study to encourage the use of auxiliary label, we have performed a survey analysis of familiarity and willingness of community pharmacists to use the auxiliary label. About three quarters of the participating community pharmacists have heard of the auxiliary label, however, there was not a single pharmacist who uses the label. Furthermore, only one fifth of the participating pharmacists were willing to use the label if they have to purchase. Therefore, it is recommended that governmental and non-profit organizations such as Korean Pharmaceutical Association educate community pharmacists regarding usefulness of the auxiliary label with focus on enhancing patient compliance and constrainment of healthcare expense.